J45.01人急性T淋巴細(xì)胞白
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/4/24 14:34:18
- 訪問次數(shù) 76
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息，謝謝!
產(chǎn)品名稱：J45.01人急性T淋巴細(xì)胞白血病細(xì)胞、J45.01人急性T淋巴細(xì)胞白血病細(xì)胞、J45.01人急性T淋巴細(xì)胞白血病細(xì)胞、J45.01人急性T淋巴細(xì)胞白血病細(xì)胞；
J45.01 人急性T淋巴細(xì)胞白血病細(xì)胞
Catalogue No.: C968
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a 15 ml centrifuge tube | 2X106 |
| Manual | 1 copy |
most dominant TCR was approved to be tumor-speci?c TCR which was used in our study. TCRa/β chains were synthesised (GenScript) and cloned into our lentivirus vector. TCRs were constructed in a β-a chain order, and their constant regions were replaced by mouse counterparts modi?ed with hydrophobic substitution and added disul?de bonds as previously described,11 which not only was convenient for the detection of TCR-T cells but also
采購中心
化工儀器網(wǎng)